Management
Proniras has assembled a seasoned management team, board of directors, and key product development experts that understand well the challenges associated with the development of new treatments for substance use and specialty central nervous system (CNS) disorders.
Thong Q. Le
President & CEO
Lindsay Rayle
Vice President of Finance
Christopher Toombs, PhD, DABT
Cofounder & Chief Scientific Officer
OPERATING TEAM
Andrew Chambers, MD
Addiction Psychiatry
PI for first clinical trial
Greg Coulter, Ph.D.
Drug Substance/Drug Product
Gregory Dietsch, PhD, DABT
Toxicology and Pharmacokinetics
Ken Ferguson, Ph.D.
Development
Michelle Rose, Ph.D.
Regulatory
Keri Urwin, MBA
Clinical Operations
Michelle Woods
Quality
Board of Directors
Thong Q. Le
Steven Gillis, PhD
